Glanbia faces potential legal action from Japanese firm
Chemical manufacturer Kaneka alleges that the Irish food-ingredients giant has infringed on two of its patents relating to nutritional supplements
Glanbia is facing potential legal action in the United States after a Japanese firm filed a lawsuit alleging that the Irish food-ingredients giant and its supplier had infringed on two of its patents.
Kaneka Corporation, an Osaka-based chemical manufacturing company, last month filed an action for patent infringement in Delaware against Glanbia Nutritionals and Indian firm Anthem Biosciences.
Kaneka has accused Glanbia and Anthem of infringing its patents by importing and selling a supplement known...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Irish funds industry hits record high of $4.2 trillion, new data shows
Figures compiled by Monterey Insight, an independent fund research company, show the value of Irish-domiciled funds grew by 10.4 per cent to a market size of just over $3.3 trillion.
How I work: ‘Take risks and back yourself, you don’t have to tick every box to put your hand up’
Pushing personal boundaries is what allowed Vodafone’s Sinéad Bryan to learn and achieve in her career
How to manage: Human experience will be central to recruiting new talent post-pandemic
Employers will be competing for top talent on a much bigger playing field thanks to remote working, and one of the best tools at their disposal is a focus on employees’ social and mental wellbeing
Movers and Shakers: Three senior appointments at Bank of Ireland
Michael Lauhoff, Deirdre Nicholl and Susan Brown move up the ranks within the financial institution
